BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 4, 2007
View Archived Issues
Aripiprazole improves psychotic symptoms in Alzheimer's dementia patients
Read More
Gabapentin ineffective in tinnitus studies
Read More
Pramipexole to be evaluated for Tourette's syndrome / News in Context
Read More
BioAlliance updates clinical development for Loramyc and acyclovir Lauriad
Read More
DOR BioPharma enters named patient access program with Orphan Australia for orBec
Read More
Cytos initiates two phase II studies of Immunodrug CYT003-QbG10 in allergy indications
Read More
Oasmia enters license and distribution agreement with Orion for Paclical
Read More
In vitro results suggest potential benefit of ICA-27243 as an anticonvulsant
Read More
New therapeutic agents for metabolic disorders imparted in recent patents
Read More
Recent patents describe novel psychopharmacological agents
Read More
Novel therapeutic agents for cardiovascular disorders reported in recent patent literature
Read More
Symptomatic and asymptomatic QTc prolongation observed in phase I trial of ARQ-171
Read More
FDA grants AstraZeneca six months pediatric exclusivity patent extension for Arimidex
Read More
GSK stands by Serevent and Advair following meeting with FDA
Read More
Amarin initiates phase I clinical trial of treatment for niacin-induced flushing
Read More
Sucampo Pharma initiates phase IIb study of lubiprostone in Japan
Read More
European Commission grants orphan medicinal product designation to Revlimid
Read More
First patient completes StemCells' phase I clinical trial of HuCNS-SC
Read More
Sanofi-aventis and Astellas restructure Japanese joint venture Fujisawa sanofi-aventis
Read More
Bavarian Nordic reports positive results from phase II trial of Imvamune smallpox vaccine
Read More
Forest Laboratories reports positive results from phase III study of Lexapro
Read More
Lundbeck reports third quarter 2007 results
Read More
A potential role for CLCN2 in absence epilepsy
Read More
GABA-A alpha1 subunit misfolding caused by mutations associated with juvenile myoclonic epilepsy
Read More
Pediatric hypertension indication for Novartis' Diovan receives FDA approval
Read More
Health Canada approves Merck Frosst's Isentress for HIV-1
Read More